Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 5Terminated 2Unknown 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Mesothelioma 53Advanced Solid Tumors 53Solid Tumor 51Advanced Solid Tumor 41Mesothelioma, Malignant 38Solid Tumors 35Unspecified Adult Solid Tumor, Protocol Specific 27Carcinoma, Non-Small-Cell Lung 25Retinoblastoma 14Melanoma 14Esophageal Neoplasms 14Solid Tumor, Adult 13Sarcoma 12Ovarian Neoplasms 12Lung Neoplasms 11Carcinoma, Renal Cell 11Uterine Cervical Neoplasms 10Small Cell Lung Carcinoma 10Stomach Neoplasms 9Breast Neoplasms 9Colorectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Pancreatic Neoplasms 7Neoplasm Metastasis 7Advanced Solid Tumours 7Neoplasms 6Urinary Bladder Neoplasms 5Thyroid Neoplasms 5Solitary Fibrous Tumor, Pleural 5Malignant Solid Tumor 5

Interventions

atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Solid Tumour × Other solid neoplasm × Clear all
NCT06488716 2025-12-24

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors

Genentech, Inc.

Phase 1 Terminated
12 enrolled
Other solid neoplasm

Solid Tumour

NCT01516645 2017-03-16

Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors

Kyowa Kirin Co., Ltd.

Phase 1 Terminated
14 enrolled
Other solid neoplasm

Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡